Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Apr 15;7(5):2518-26.
eCollection 2014.

Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions

Affiliations
Comparative Study

Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions

Kosuke Miyai et al. Int J Clin Exp Pathol. .

Abstract

Intraductal carcinoma of the prostate (IDC-P) has been described as a lesion associated with intraductal spread of invasive carcinoma and consequently aggressive disease. However, there are a few reported cases of pure IDC-P without an associated invasive component, strongly suggesting that this subset of IDC-P may represent a precursor lesion. We compared the clinicopathological features between the morphologically "regular type" IDC-P and "precursor-like" IDC-P. IDC-P was defined as follows; 1) solid/dense cribriform lesions or 2) loose cribriform/micropapillary lesions with prominent nuclear pleomorphism and/or non-focal comedonecrosis. We defined precursor-like IDC-P as follows; 1) IDC-P without adjoining invasive adenocarcinoma but carcinoma present distant from the IDC-P or 2) IDC-P having adjoining invasive microcarcinoma (less than 0.05 ml) and showing a morphologic transition from high-grade prostatic intraepithelial neoplasia (HGPIN) to the IDC-P. IDC-P lacking the features of precursor-like IDC-P was categorized as regular type IDC-P. Of 901 radical prostatectomies performed at our hospital, 141 and 14 showed regular type IDC-P and precursor-like IDC-P in whole-mounted specimens, respectively. Regular type IDC-P cases had significantly higher Gleason score, more frequent extraprostatic extension and seminal vesicle invasion, more advanced pathological T stage, and lower 5-year biochemical recurrence-free rate than precursor-like IDC-P cases. Multivariate analysis revealed nodal metastasis and the presence of regular type IDC-P as independent predictors for biochemical recurrence. Our data suggest that IDC-P may be heterogeneous with variable clinicopathological features. We also suggest that not all IDC-P cases represent intraductal spread of pre-existing invasive cancer, and a subset of IDC-P may be a precursor lesion.

Keywords: Prostate; high-grade prostatic intraepithelial neoplasia; intraductal carcinoma of prostate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Precursor-like intraductal carcinoma of the prostate (IDC-P). (A) A case with a intraductal lesion having adjoining invasive microcarcinoma and showing recognizable morphologic transition from high-grade prostatic intraepithelial neoplasia (HGPIN) to IDC-P. (B) HGPIN component. (C) IDC-P component with dense cribriform pattern and necrosis. (D) Invasive microcarcinoma component with Gleason patterns 3 and 4. Immunohistochemical staining for high molecular weight cytokeratin highlighting the presence of basal cells in IDC-P component (E) and the absence of basal cell in invasive microcarcinoma component (F). Hematoxylin and eosin stain, original magnification ×20 for (A) and ×100 for (B-D). Immunoperoxidase stain, original magnification ×100 for (E and F).
Figure 2
Figure 2
Kaplan-Meier estimates of biochemical recurrence-free survival for 151 patients with intraductal carcinoma of the prostate (IDC-P), stratified by regular type or precursor-like IDC-P. Solid line curve for cases with regular type IDC-P (n = 137), and dashed line curve for cases with precursor-like IDC-P (n = 14).

Similar articles

Cited by

References

    1. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol. 1996;20:802–814. - PubMed
    1. Cohen RJ, McNeal JE, Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate. 2000;43:11–19. - PubMed
    1. Rhamy RH, Buchanan RD, Spalding MJ. Intraductal carcinoma of the prostate gland. J Urol. 1973;109:457–460. - PubMed
    1. Catalona WJ, Kadmon D, Martin SA. Surgical considerations in treatment of intraductal carcinoma of the prostate. J Urol. 1978;120:259–261. - PubMed
    1. Henry PC, Evans AJ. Intraductal carcinoma of the prostate: a distinct histopathological entity with important prognostic implications. J Clin Pathol. 2009;62:579–583. - PubMed

Publication types

MeSH terms